Is Psilocybin Legal in Oregon? A Plain-English 2026 Status Guide

Yes—with a major caveat. In Oregon, adults 21+ can legally consume psilocybin at state-licensed psilocybin service centers under Measure 109 (Oregon Psilocybin Services, launched in 2023), and no prescription is required. But psilocybin remains a Schedule I controlled substance under U.S. federal law, and it has no Food and Drug Administration (FDA) approval. That means possession or use outside the licensed Oregon program can still create legal risk—especially under federal law.

This explainer is general information, not legal advice.

What Oregon law allows under Measure 109

Measure 109 created a state-regulated framework for psilocybin services in Oregon. The core legal permission is narrow and specific: psilocybin can be consumed by adults at licensed service centers, under the supervision of licensed facilitators.

Key features of Oregon’s framework, as implemented through Oregon Psilocybin Services:

• Consumption is allowed at licensed service centers (not as a general “legalization” of mushrooms).
• No physician referral or prescription is required.
• Clients must be 21 or older.
• Psilocybin is administered in a regulated service model led by licensed facilitators at licensed premises.

Operationally, the program is no longer experimental: as of 2026, over 100 service centers are licensed and operating statewide. That scale matters for practical access (availability, pricing, travel), but it does not change the underlying legal structure: Oregon permits psilocybin services, not broad retail sales or unrestricted possession.

If you’re comparing Oregon to other states, Colorado has also launched state-level therapeutic access (via Proposition 122, rolling out across 2024–2025). Oregon remains distinctive for being the first state with a mature, statewide service-center model.

For background on how supervised psychedelic programs fit into the broader U.S. policy landscape, see our primers at /law and the overview at /psychedelic-research-landscape.

Why federal law still matters: Schedule I and no FDA approval

Even when a state builds a legal pathway, federal drug law doesn’t automatically change. Under the U.S. Controlled Substances Act, psilocybin is Schedule I. “Schedule I” is the most restrictive category, and it generally means federal law prohibits possession, manufacture, and distribution except under tightly controlled research conditions.

Two implications follow from the status you provided:

• Schedule I status remains nationwide, including in Oregon.
• No FDA-approved psilocybin product exists for routine medical prescribing in the United States.

This is why it’s most accurate to describe Oregon’s approach as a state-licensed supervised access model that exists alongside (and potentially in tension with) federal prohibition. Oregon can define what is permitted under state law, but it cannot “reschedule” psilocybin federally.

In practical terms, people often summarize this as: legal to consume in the Oregon program; not a blanket legalization outside it. That’s a simplification, but it captures the core point: legality hinges on where and how psilocybin is used.

Decriminalization vs. licensed services: Measure 110 and HB 4002

Oregon’s psilocybin “legality” conversation is frequently confused by a second policy track: drug possession enforcement.

Measure 110 (2020) is commonly described as “decriminalizing all drug possession.” That policy landscape later shifted: House Bill (HB) 4002 (2024) partially rolled back Measure 110 by restoring misdemeanor personal-use possession.

These are distinct from Measure 109:

• Measure 109 creates a licensed program for supervised psilocybin services.
• Measure 110 / HB 4002 concerns criminal penalties and enforcement for personal possession more generally.

Why this matters: a person can be fully compliant with Measure 109 (using psilocybin only at a licensed service center) and still be subject to federal Schedule I rules in a broader sense—while the state’s posture on personal possession outside the program has also changed over time due to HB 4002. Put simply, don’t assume “Oregon has psilocybin services” means “possession is always fine”.

How the Oregon psilocybin services model works

Oregon’s legal pathway is not a pharmacy model and not traditional “medical marijuana-style” retail. It is a facilitated services model built around controlled settings and professional oversight.

At a high level, Measure 109 authorizes:

• Licensed facilitators who guide clients through preparation, administration, and integration within the program’s rules.
• Licensed service centers where the session occurs.
• A regulated supply chain that supports service delivery under state licensing.

No prescription required is one of the headline differences between Oregon’s program and FDA-approved medicine pathways. It also helps explain why critics and supporters often talk past each other: Oregon’s program is a state public-health and consumer-safety framework, not an FDA-label-based medical treatment pathway.

Oregon has also continued to refine governance of the program. For example, Senate Bill (SB) 303 (2023) established data collection rules for the Measure 109 program—an attempt to make the system more legible and measurable over time (important for policymakers, researchers, and journalists assessing outcomes).

Readers looking for a broader view of how real-world services connect to evidence standards can follow our research and policy updates at /briefing.

Common questions people ask (and straight answers)

Is psilocybin “legal to buy” in Oregon?Measure 109 makes psilocybin legal to consume within licensed service centers as part of a regulated service. Oregon’s framework is not best understood as general retail legality for take-home products.

Can I possess psilocybin mushrooms at home if I’m in Oregon?Your curated status is clear: personal possession outside a service center remains technically illegal under federal law, because psilocybin is Schedule I. (State enforcement posture has also evolved due to the Measure 110 rollback via HB 4002, but federal Schedule I status remains unchanged.)

Do I need a diagnosis or doctor’s referral?No. Under Measure 109 services, no prescription is required, and clients must be 21+.

Is psilocybin FDA-approved anywhere in the U.S.?No. There is no FDA approval for psilocybin. However, late-stage clinical development is active: Compass Pathways’ COMP360 program is in Phase 3 with readouts expected across 2025–2026, and Usona’s IPR001 is also in Phase 3 (ongoing). These trials are part of the conventional drug-approval pathway, separate from Oregon’s service model.

Does Oregon’s program prove psilocybin is safe or effective?A licensed service framework is a regulatory choice, not the same as FDA approval. Oregon and Colorado have generated growing real-world program data, and studies have reported mental health benefits alongside safety concerns (including reports of increased suicidality in some analyses). The evergreen takeaway is: evidence and monitoring remain central, especially as access expands beyond clinical trials into supervised public programs.

What to do next

If your goal is to stay compliant, start by separating three questions: (1) what Oregon permits under Measure 109, (2) what Oregon enforces for possession after HB 4002, and (3) what federal Schedule I status prohibits. The legally “safe” lane in Oregon is the narrow one: participate only through licensed service centers with licensed facilitators.

For continued context, use:

• /start for a structured introduction to our psychedelics coverage.
• /law for legal and regulatory explainers across jurisdictions.
• /briefing to track research and policy developments without relying on hype.
• /guides for practical, topic-specific reading lists.

If you need advice for a specific situation (employment screening, travel, licensing, or criminal exposure), consult a qualified Oregon attorney; this explainer can’t assess individual facts.